Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes

This publication has 42 references indexed in Scilit:

• Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes
  Circulation, 2004
• Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention
  Published by Oxford University Press (OUP) ,2003
• Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE) *
  Published by Elsevier ,2002
• Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes
  American Heart Journal, 2001
• Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris
  The American Journal of Cardiology, 2000
• Circulating Levels of Secretory Type II Phospholipase A ₂ Predict Coronary Events in Patients with Coronary Artery Disease
  Circulation, 1999
• Role of Group II Secretory Phospholipase A₂in Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Expression of Phospholipase A ₂ Isoforms in Human Normal and Atherosclerotic Arterial Wall
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release
  Biochemical and Biophysical Research Communications, 1991
• A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin
  Analytical Biochemistry, 1989